Ferroptosis inducer-9
Ferroptosis inducer-9 is a ferroptosis inducer and colchicine site tubulin polymerization inhibitor. Ferroptosis inducer-9 inhibits MCF-7 cell growth with an IC50 of 14 nM and inhibits [3H]colchicine binding. Ferroptosis inducer-9 reduces expression of GPX4 and FTH, increases COX2 and ACSL4, lowers GSH, NADP+, and NADPH levels, increases LPO, MDA, and Fe(II) levels, and decreases SOD concentrations. Ferroptosis inducer-9 demonstrates significant anti-tumor efficacy in HCT116 CRC xenograft model. Ferroptosis inducer-9 can be used for the study of triple negative breast cancer (TNBC) and colorectal cancer (CRC).
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C21H18N2O5S
- 分子量:410.44
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
|
GPX4 |
ACSL4 |
Ferroptosis inducer-9 (Compound 12) inhibits tubulin polymerization (IC50 = 550 nM) and MCF-7 cell growth (IC50 = 14 nM)[1].
Ferroptosis inducer-9 (0.3-1 μM) lead to total cell growth arrest and profound nuclear and cytoskeletal morphological alterations in H2BC11-moxGFP/sTagRFP-TUBA1B tagged MDA-MB-231 cells [1].
Ferroptosis inducer-9 (72 h) inhibits the growth of SW620, SW480, HCT116, HepG2 and CC-2509f cells with IC50 values of 0.633 μM, 0.0654 μM, 0.389 μM, 107.3μM, 52.9 μM, respectively[1].
Ferroptosis inducer-9 reduces the expression of ferroptosis inhibitory factors (SLC7A11, SLC3A2, SLC11A2, NRF2, NCOA4, KEAP1, GPX4, FTL, FTH1) and increases the expression of ferroptosis promoting factors (PTGS2, NOX1, COX2, COX4, ACSL4) in HCT116 cells[1].
Ferroptosis inducer-9 decreases GSH and SOD concentration, lowers NADP+ and NADPH concentrations, increases LPO, MDA, and Fe(II) levels and GSSG concentration[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:HCT116 colorectal cancer cells (1×108 cells/mL in logarithmic growth phase) were subcutaneously implanted into the flanks of 10-week-old male BALB/C mice[1]
-
Dosage:25 mg/kg
-
Administration:intraperitoneal injection, once every 2 days for 30 days
-
Result:Achieved tumor growth inhibition.
Reduced the Ki67 expression.
化学情報
-
分子量 410.44
-
分子式 C21H18N2O5S
-
SMILES
O=C(C1=CN(C2=NC=CS2)C=C1C3=CC=CO3)C4=CC(OC)=C(OC)C(OC)=C4
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Ferroptosis inducer-9 関連分類
HY-175698 関連分類
Powered by Bioz